Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

45 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
GF-15, a novel inhibitor of centrosomal clustering, suppresses tumor cell growth in vitro and in vivo.
Raab MS, Breitkreutz I, Anderhub S, Rønnest MH, Leber B, Larsen TO, Weiz L, Konotop G, Hayden PJ, Podar K, Fruehauf J, Nissen F, Mier W, Haberkorn U, Ho AD, Goldschmidt H, Anderson KC, Clausen MH, Krämer A. Raab MS, et al. Among authors: nissen f. Cancer Res. 2012 Oct 15;72(20):5374-85. doi: 10.1158/0008-5472.CAN-12-2026. Epub 2012 Aug 31. Cancer Res. 2012. PMID: 22942257
Peptide arrays for development of PDGFRβ Affine molecules.
Marr A, Nissen F, Maisch D, Altmann A, Rana S, Debus J, Huber PE, Haberkorn U, Askoxylakis V. Marr A, et al. Among authors: nissen f. Mol Imaging Biol. 2013 Aug;15(4):391-400. doi: 10.1007/s11307-013-0616-0. Mol Imaging Biol. 2013. PMID: 23381728
Fracture liaison service (FLS) is associated with lower subsequent fragility fracture risk and mortality: NoFRACT (the Norwegian capture the fracture initiative).
Andreasen C, Dahl C, Frihagen F, Borgen TT, Basso T, Gjertsen JE, Figved W, Wisløff T, Hagen G, Apalset EM, Stutzer JM, Lund I, Hansen AK, Nissen FI, Joakimsen RM, Syversen U, Eriksen EF, Nordsletten L, Omsland TK, Bjørnerem Å, Solberg LB. Andreasen C, et al. Among authors: nissen fi. Osteoporos Int. 2025 Jan 14. doi: 10.1007/s00198-024-07376-y. Online ahead of print. Osteoporos Int. 2025. PMID: 39808195
An assessment of burden associated with problem joints in children and adults with moderate or severe haemophilia A: analysis of the CHESS-Paediatrics and CHESS II cross-sectional studies.
McLaughlin P, De la Corte-Rodriguez H, Burke T, Nissen F, Aizenas M, Moreno K, O'Hara J. McLaughlin P, et al. Among authors: nissen f. Orphanet J Rare Dis. 2025 Jan 13;20(1):18. doi: 10.1186/s13023-024-03514-1. Orphanet J Rare Dis. 2025. PMID: 39806420 Free PMC article.
Emicizumab is well tolerated and effective in people with congenital hemophilia A regardless of age, severity of disease, or inhibitor status: a scoping review.
Young G, Pipe SW, Kenet G, Oldenburg J, Safavi M, Czirok T, Nissen F, Mahlangu J. Young G, et al. Among authors: nissen f. Res Pract Thromb Haemost. 2024 Apr 18;8(4):102415. doi: 10.1016/j.rpth.2024.102415. eCollection 2024 May. Res Pract Thromb Haemost. 2024. PMID: 38812987 Free PMC article. Review.
45 results